Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
The Journal of Cell Biology
|
July 1, 1994
The bovine desmocollin family: a new gene and expression patterns reflecting epithelial cell proliferation and differentiation
P K Legan, K K Yue, M A Chidgey, et al.
British Journal of Cancer
|
October 12, 2000
A transgenic mouse model for tumour immunotherapy: induction of an anti-idiotype response to human MUC1
R W Wilkinson, E L Ross, A E Lee-MacAry, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 23, 2001
Antibody targeting studies in a transgenic murine model of spontaneous colorectal tumors
R W Wilkinson, E L Ross, R Poulsom, et al.
Journal of Immunological Methods
|
May 4, 2001
Development of a novel flow cytometric cell-mediated cytotoxicity assay using the fluorophores PKH-26 and TO-PRO-3 iodide
A E Lee-MacAry, E L Ross, D Davies, et al.
Journal of Theoretical Biology
|
October 4, 2017
A mathematical model of antibody-dependent cellular cytotoxicity (ADCC)
F Hoffman, D Gavaghan, J Osborne, et al.
British Journal of Cancer
|
February 21, 2012
The MEK1/2 inhibitor, selumetinib (AZD6244; ARRY-142886), enhances anti-tumour efficacy when combined with conventional chemotherapeutic agents in human tumour xenograft models
S V Holt, A Logié, R Odedra, et al.
Cancer Immunology, Immunotherapy : CII
|
April 15, 1999
Humanisation and characterisation of PR1A3, a monoclonal antibody specific for cell-bound carcinoembryonic antigen
L M Stewart, S Young, G Watson, et al.
Carcinogenesis
|
June 20, 2006
Inhibiting vascular endothelial growth factor receptor-2 signaling reduces tumor burden in the ApcMin/+ mouse model of early intestinal cancer
R A Goodlad, A J Ryan, S R Wedge, et al.
Cancer Biomarkers : Section a of Disease Markers
|
May 2, 2009
Specific demonstration of drug-induced tumour cell apoptosis in human xenografts models using a plasma biomarker
M Hägg Olofsson, J Cummings, W Fayad, et al.
International Journal of Colorectal Disease
|
May 3, 2005
Immune responses in advanced colorectal cancer following repeated intradermal vaccination with the anti-CEA murine monoclonal antibody, PR1A3: results of a phase I study
A P Zbar, H Thomas, R W Wilkinson, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
The Journal of Cell Biology
|
July 1, 1994
The bovine desmocollin family: a new gene and expression patterns reflecting epithelial cell proliferation and differentiation
P K Legan, K K Yue, M A Chidgey, et al.
British Journal of Cancer
|
October 12, 2000
A transgenic mouse model for tumour immunotherapy: induction of an anti-idiotype response to human MUC1
R W Wilkinson, E L Ross, A E Lee-MacAry, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 23, 2001
Antibody targeting studies in a transgenic murine model of spontaneous colorectal tumors
R W Wilkinson, E L Ross, R Poulsom, et al.
Journal of Immunological Methods
|
May 4, 2001
Development of a novel flow cytometric cell-mediated cytotoxicity assay using the fluorophores PKH-26 and TO-PRO-3 iodide
A E Lee-MacAry, E L Ross, D Davies, et al.
Journal of Theoretical Biology
|
October 4, 2017
A mathematical model of antibody-dependent cellular cytotoxicity (ADCC)
F Hoffman, D Gavaghan, J Osborne, et al.
British Journal of Cancer
|
February 21, 2012
The MEK1/2 inhibitor, selumetinib (AZD6244; ARRY-142886), enhances anti-tumour efficacy when combined with conventional chemotherapeutic agents in human tumour xenograft models
S V Holt, A Logié, R Odedra, et al.
Cancer Immunology, Immunotherapy : CII
|
April 15, 1999
Humanisation and characterisation of PR1A3, a monoclonal antibody specific for cell-bound carcinoembryonic antigen
L M Stewart, S Young, G Watson, et al.
Carcinogenesis
|
June 20, 2006
Inhibiting vascular endothelial growth factor receptor-2 signaling reduces tumor burden in the ApcMin/+ mouse model of early intestinal cancer
R A Goodlad, A J Ryan, S R Wedge, et al.
Cancer Biomarkers : Section a of Disease Markers
|
May 2, 2009
Specific demonstration of drug-induced tumour cell apoptosis in human xenografts models using a plasma biomarker
M Hägg Olofsson, J Cummings, W Fayad, et al.
International Journal of Colorectal Disease
|
May 3, 2005
Immune responses in advanced colorectal cancer following repeated intradermal vaccination with the anti-CEA murine monoclonal antibody, PR1A3: results of a phase I study
A P Zbar, H Thomas, R W Wilkinson, et al.
Page
of 3